Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1

Mechanisms of Ageing and Development

Volumn 130, Issue 8, 2009, Pages 528-537

  Rusin, Marek ^a   Zajkowicz, Artur ^a   Butkiewicz, Dorota ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

BRCA1; Cell cycle; Senescence; Telomere; WRN

Indexed keywords

BRCA1 PROTEIN; CYCLIN B1; DNA; HISTONE H2AX; PROTEIN P21; PROTEIN P53; RESVERATROL; RETINOBLASTOMA PROTEIN; SERINE; TELOMERIC REPEAT BINDING FACTOR 1; WERNER SYNDROME PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE REGULATION; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA DAMAGE; DNA METABOLISM; DNA REPAIR; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SENESCENCE; SIGNAL TRANSDUCTION; TELOMERE; UPREGULATION;

ANTIOXIDANTS; BLOTTING, SOUTHERN; BRCA1 PROTEIN; CELL AGING; CELL LINE, TUMOR; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MODELS, BIOLOGICAL; SERINE; SIRTUINS; STILBENES; TELOMERE; UP-REGULATION;

ANIMALIA;

EID: 67650677845     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2009.06.005     Document Type: Article

References (43)

1. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., and Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
2. Bryan T.M., Englezou A., Gupta J., Bacchetti S., and Reddel R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14 (1995) 4240-4248
3. Cerone M.A., Londono-Vallejo J.A., and Bacchetti S. Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum. Mol. Genet. 10 (2001) 1945-1952
4. Cheng W.H., Kusumoto R., Opresko P.L., Sui X., Huang S., Nicolette M.L., Paull T.T., Campisi J., Seidman M., and Bohr V.A. Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links. Nucleic Acids Res. 34 (2006) 2751-2760
5. Choudhury A.D., Xu H., and Baer R. Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression. J. Biol. Chem. 279 (2004) 33909-33918
6. Delmas D., Lançon A., Colin D., Jannin B., and Latruffe N. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr. Drug Targets 7 (2006) 423-442
7. Deng C.X. BRCA1: cell cycle checkpoint, genetic instability. DNA damage response and cancer evolution. Nucleic Acids Res. 34 (2006) 1416-1426
8. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., Peacocke M., and Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9363-9367
9. Fasching C.L., Neumann A.A., Muntoni A., Yeager T.R., and Reddel R.R. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. Cancer Res. 67 (2007) 7072-7077
10. Flatt P.M., Tang L.J., Scatena C.D., Szak S.T., and Pietenpol J.A. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol. Cell. Biol. 20 (2000) 4210-4223
11. Geley S., Kramer E., Gieffers C., Gannon J., Peters J.M., and Hunt T. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol. 153 (2001) 137-148
12. Heiss E.H., Schilder Y.D., and Dirsch V.M. Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells. J. Biol. Chem. 282 (2007) 26759-26766
13. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., and Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
14. Innocente S.A., Abrahamson J.L., Cogswell J.P., and Lee J.M. p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 2147-2152
15. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
16. Johnson F.B., Marciniak R.A., McVey M., Stewart S.A., Hahn W.C., and Guarente L. The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J. 20 (2001) 905-913
17. Karmakar P., and Bohr V.A. Cellular dynamics and modulation of WRN protein is DNA damage specific. Mech. Ageing Dev. 126 (2005) 1146-1158
18. Kahyo T., Mostoslavsky R., Goto M., and Setou M. Sirtuin-mediated deacetylation pathway stabilizes Werner syndrome protein. FEBS Lett. 582 (2008) 2479-2483
19. Kudlow B.A., Kennedy B.K., and Monnat Jr. R.J. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat. Rev. Mol. Cell Biol. 8 (2007) 394-404
20. Li K., Casta A., Wang R., Lozada E., Fan W., Kane S., Ge Q., Gu W., Orren D., and Luo J. Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation. J. Biol. Chem. 283 (2008) 7590-7598
21. Ludlow J.W., Glendening C.L., Livingston D.M., and DeCarprio J.A. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 13 (1993) 367-372
22. Matsuoka A., Furuta A., Ozaki M., Fukuhara K., and Miyata N. Resveratrol, a naturally occurring polyphenol, induces sister chromatid exchanges in a Chinese hamster lung (CHL) cell line. Mutat. Res. 494 (2001) 107-113
23. MacLachlan T.K., Takimoto R., and El-Deiry W.S. BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol. Cell. Biol. 22 (2002) 4280-4292
24. Olsson A., Manzl C., Strasser A., and Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?. Cell Death Differ. 14 (2007) 1561-1575
25. Ongusaha P.P., Ouchi T., Kim K.T., Nytko E., Kwak J.C., Duda R.B., Deng C.X., and Lee S.W. BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest. Oncogene 22 (2003) 3749-3758
26. Ouyang K.J., Woo L.L., and Ellis N.A. Homologous recombination and maintenance of genome integrity: cancer and aging through the prism of human RecQ helicases. Mech. Ageing Dev. 129 (2008) 425-440
27. Paulsen R.D., and Cimprich K.A. The ATR pathway: fine-tuning the fork. DNA Repair (Amst) 6 (2007) 953-966
28. Pichierri P., Rosselli F., and Franchitto A. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle. Oncogene 22 (2003) 1491-1500
29. Quincozes-Santos A., Andreazza A.C., Nardin P., Funchal C., Gonçalves C.A., and Gottfried C. Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells. Neurotoxicology 28 (2007) 886-891
30. Riou J.F., Guittat L., Mailliet P., Laoui A., Renou E., Petitgenet O., Mégnin-Chanet F., Hélène C., and Mergny J.L. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 2672-2677
31. Scheel C., Schaefer K.L., Jauch A., Keller M., Wai D., Brinkschmidt C., van Valen F., Boecker W., Dockhorn-Dworniczak B., and Poremba C. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20 (2001) 3835-3844
32. Sakamoto S., Nishikawa K., Heo S.J., Goto M., Furuichi Y., and Shimamoto A. Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51. Genes Cells 6 (2001) 421-430
33. Schmitt E., Lehmann L., Metzler M., and Stopper H. Hormonal and genotoxic activity of resveratrol. Toxicol. Lett. 136 (2002) 133-142
34. Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., and Livingston D.M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90 (1997) 425-435
35. Scully R., Xie A., and Nagaraju G. Molecular functions of BRCA1 in the DNA damage response. Cancer Biol. Ther. 3 (2004) 521-527
36. Sgambato A., Ardito R., Faraglia B., Boninsegna A., Wolf F.I., and Cittadini A. Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat. Res. 496 (2001) 171-180
37. Signorelli P., and Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 16 (2005) 449-466
38. Stiff T., O'Driscoll M., Rief N., Iwabuchi K., Löbrich M., and Jeggo P.A. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 64 (2004) 2390-2396
39. Tyagi A., Singh R.P., Agarwal C., Siriwardana S., Sclafani R.A., and Agarwal R. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26 (2005) 1978-1987
40. Vaitiekunaite R., Butkiewicz D., Krześniak M., Przybyłek M., Gryc A., Snietura M., Benedyk M., Harris C.C., and Rusin M. Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML. Mech. Ageing Dev. 128 (2007) 650-661
41. Ward I.M., and Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276 (2001) 47759-47762
42. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., and Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430 (2004) 686-689
43. Wu G., Jiang X., Lee W.H., and Chen P.L. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res. 63 (2003) 2589-2595